MeiraGTx Holdings plc Contracts & Agreements

Non-Employee Director Compensation Program (Filed With SEC on August 12, 2024)

Termination Agreement, dated December 20, 2023, by and among Janssen Pharmaceuticals, Inc., MeiraGTx UK II Limited and MeiraGTx Holdings plc (Filed With SEC on March 15, 2024)

Asset Purchase Agreement, dated December 20, 2023, by and among Janssen Pharmaceuticals, Inc., MeiraGTx UK II Limited and MeiraGTx Holdings plc (Filed With SEC on March 15, 2024)

Consent and Amendment to Amended and Restated Notes Purchase Agreement and Guaranty, dated December 20, 2023, by and among MeiraGTx Holdings plc, as issuer, the subsidiary... (Filed With SEC on March 15, 2024)

Registration Rights Agreement, dated October 30, 2023, by and between MeiraGTx Holdings plc and Sanofi Foreign Participations B.V (Filed With SEC on October 30, 2023)

Investment Agreement, dated October 30, 2023, by and among MeiraGTx Holdings plc, Sanofi Foreign Participations B.V. and Sanofi (Filed With SEC on October 30, 2023)

Consent and Amendment to Amended and Restated Note Purchase Agreement and Guaranty, dated August 10, 2023, by and among MeiraGTx Holdings plc, as issuer, the subsidiary guarantors... (Filed With SEC on August 10, 2023)

Non-Employee Director Compensation Program (Filed With SEC on August 10, 2023)

First Amendment to Registration Rights Agreement, dated May 12, 2023, by and among MeiraGTx Holdings plc and Johnson & Johnson Innovation JJDC, Inc (Filed With SEC on August 10, 2023)

Form of Restricted Share Unit Grant Notice and Restricted Share Unit Agreement for Non-Employee Directors Under the 2018 Incentive Award Plan (Filed With SEC on March 14, 2023)

Form of Warrant Agreement, dated August 2, 2022, issued by MeiraGTx Holdings plc to certain warrant holders (Filed With SEC on November 10, 2022)

Deferred Compensation Plan for Non-Employee Directors (Filed With SEC on March 10, 2022)

First Amendment to Collaboration, Option and License Agreement, dated December 16, 2021 (Filed With SEC on March 10, 2022)

Form of Restricted Share Unit Grant Notice and Restricted Share Unit Agreement for Non-Employee Directors Under the 2018 Incentive Award Plan (Filed With SEC on March 10, 2022)

Non-Employee Director Compensation Program (Filed With SEC on August 11, 2021)

Form of Change in Control Agreement (Filed With SEC on March 11, 2021)

Non-Employee Director Compensation Program (Filed With SEC on March 11, 2021)

Underwriting Agreement, dated November 19, 2020, by and among the Company and BofA Securities, Inc., Piper Sandler & Co., Evercore Group L.L.C. and Barclays Capital Inc., as... (Filed With SEC on November 23, 2020)

Particulars and Conditions of Sale of Building 3, Block K, Shannon Free Zone, Shannon, County Clare, Ireland, dated as of August 4, 2020, by and between Shannon Commercial... (Filed With SEC on November 5, 2020)

Particulars and Conditions of Sale of Building 2, Block K, Shannon Free Zone, Shannon, County Clare, Ireland, dated as of August 4, 2020, by and between Shannon Commercial... (Filed With SEC on November 5, 2020)

Separation and Release Agreement, dated January 7, 2020, between MeiraGTx Holdings plc and Bruce Gottlieb (Filed With SEC on May 7, 2020)

Shareholder Agreement (Filed With SEC on March 11, 2020)

Form of Restricted Share Unit Grant Notice and Restricted Share Unit Agreement Under the UK Sub-Plan to the 2018 Incentive Award Plan (Filed With SEC on March 11, 2020)

Form of Restricted Share Unit Grant Notice and Restricted Share Unit Agreement Under the 2018 Incentive Award Plan (Filed With SEC on March 11, 2020)

Non-Employee Director Compensation Program (Filed With SEC on March 11, 2020)

Description of Securities (Filed With SEC on March 11, 2020)

Underwriting Agreement, dated August 7, 2019, by and among the Company and BofA Securities, Inc. and Piper Jaffray & Co., as representatives of the underwriters named therein (Filed With SEC on August 9, 2019)

Agreement for Lease with Landlords Refurbishment Works, dated May 29, 2019, between MeiraGTx UK II Limited and Provost 1 Limited and Provost 2 Limited, including agreed form of... (Filed With SEC on August 7, 2019)

License and Sub-Lease Agreement, dated May 31, 2019, between MeiraGTx LLC and Imclone Systems, LLC (Filed With SEC on August 7, 2019)

Separation and Release Agreement, dated June 3, 2019, between MeiraGTx Holdings plc and Katherine Breedis (Filed With SEC on June 4, 2019)

Employment Agreement, dated March 25, 2019, between Meira GTx, LLC and Bruce Gottlieb (Filed With SEC on May 14, 2019)

Form of Option Grant Notice and Option Agreement Under the UK Sub-Plan to the 2018 Incentive Award Plan (Filed With SEC on March 26, 2019)

UK Sub-Plan Under the 2018 Incentive Award Plan (Filed With SEC on March 26, 2019)

Consulting Agreement, dated October 5, 2018, between MeiraGTx Holdings plc, Vector Consulting LLC, Michael G. Kaplitt, Matthew During, and Stephen B. Kaplitt (Filed With SEC on March 26, 2019)

License Agreement (RPE65), dated January 29, 2019, as amended and restated by and among UCL Business PLC, MeiraGTx UK II Limited and MeiraGTx Limited (Filed With SEC on March 26, 2019)

License Agreement (CNGB3), dated January 29, 2019, as amended and restated by and among UCL Business PLC, MeiraGTx Holdings plc, MeiraGTx UK II Limited and MeiraGTx Limited (Filed With SEC on March 26, 2019)

License Agreement (CNGA3), dated January 29, 2019, as amended and restated by and among UCL Business PLC, MeiraGTx UK II Limited and MeiraGTx Limited (Filed With SEC on March 26, 2019)

License Agreement (RPGR), dated February 5, 2019, as amended and restated by and among UCL Business PLC, MeiraGTx UK II Limited and MeiraGTx Limited (Filed With SEC on March 26, 2019)

Amendment No. 4 to Exclusive License Agreement, dated January 29, 2019, between UCLB and MeiraGTx Limited (Filed With SEC on March 26, 2019)

Collaboration, Option and License Agreement, dated January 30, 2019, by and among Janssen Pharmaceuticals, Inc., MeiraGTx UK II Limited and MeiraGTx Holdings plc (Filed With SEC on March 26, 2019)

Agreement and Plan of Merger, dated October 5, 2018, by and among MeiraGTx Holdings plc, Vector Neurosciences Inc., VN Acquisition, Inc., VN Acquisition 2, Inc., the Vector... (Filed With SEC on March 26, 2019)

Registration Right Agreement, by and among the Company and the Investors named therein, dated February 26, 2019 (Filed With SEC on March 4, 2019)

Securities Purchase Agreement, by and among the Company and the Investors named therein, dated February 26, 2019 (Filed With SEC on March 4, 2019)

Transfer of Title, dated December 14, 2018, and Lease, dated October 12, 2001, relating to the Pharmacy Manufacturing Unit, Britannia Walk, London, England (Filed With SEC on December 20, 2018)

Overage Deed, dated December 14, 2018, between Moorfields Eye Hospital NHS Foundation Trust and MeiraGTx UK II Limited relating to the Pharmacy Manufacturing Unit, Britannia Walk,... (Filed With SEC on December 20, 2018)

Employment Offer Letter, dated October 2, 2018, between MeiraGTx Holdings plc and Katherine Breedis (Filed With SEC on October 9, 2018)

Lease agreement by and between Moorfields Eye Hospital NHS Foundation Trust and MeiraGTx UK II Limited, dated July 30, 2018 (Filed With SEC on August 8, 2018)

Lease agreement by and between Moorfields Eye Hospital NHS Foundation Trust and MieraGTx UK II Limited, dated July 30, 2018 (Filed With SEC on August 8, 2018)

Form of Shareholder Agreement (to be effective upon consummation of the Corporate Reorganization) (Filed With SEC on June 4, 2018)

Form of Underwriting Agreement (Filed With SEC on June 4, 2018)

2018 Employee Share Purchase Plan (Filed With SEC on May 29, 2018)

Specimen Share Certificate evidencing the ordinary shares of the Registrant (Filed With SEC on May 29, 2018)

Agreement and Plan of Merger, dated December 31, 2015, among MeiraGTx Acquisition Corporation, BRI-Alzan, Inc., F-Prime Inc., Gregory Petsko, Dagmar Ringe, Brandeis University and... (Filed With SEC on May 29, 2018)

License Agreement, dated March 15, 2018, among MeiraGTx Limited, MeiraGTx UKII-Limited and UCL Business Plc (Filed With SEC on May 29, 2018)

License Agreement, dated July 28, 2017, as amended, between MeiraGTx UKII Limited and UCL Business, Plc (Filed With SEC on May 29, 2018)

License Agreement, dated February 4, 2015, as amended, between Athena Vision Ltd. and UCL Business, Plc (Filed With SEC on May 29, 2018)

License Agreement, dated May 1, 2013, as amended, among MeiraGTx Limited, Brandeis University and BRI-Alzan Inc (Filed With SEC on May 29, 2018)

Employment Agreement, dated April 27, 2015, between MeiraGTx Limited and Stuart Naylor, Ph.D (Filed With SEC on May 29, 2018)

Employment Agreement, dated February 15, 2016 between MeiraGTx Limited and Richard Giroux (Filed With SEC on May 29, 2018)

Employment Agreement, dated February 15, 2016, between MeiraGTx Limited and Alexandria Forbes, Ph.D (Filed With SEC on May 29, 2018)

Form of Indemnification Agreement for Directors and Officers (Filed With SEC on May 29, 2018)

Non-Employee Director Compensation Program (Filed With SEC on May 29, 2018)

2018 Incentive Award Plan and forms of award agreements thereunder (Filed With SEC on May 29, 2018)

2016 Equity Incentive Plan, as amended, and form of option agreements thereunder (Filed With SEC on May 29, 2018)

Lease Agreement, dated June 29, 2016, as amended, between MeiraGTx Limited and ARE-East River Science Park LLC (Filed With SEC on May 14, 2018)

Lease Agreement, effective February 2, 2016, among MeiraGTx Limited, Moorfields Eye Hospital NHS, Foundation Trust and Kadmon Corporation LLC (Filed With SEC on May 14, 2018)

Category

Industry

Companies

Contracts

MeiraGTx Holdings plc Contracts & Agreements